Fatty Acid-Binding Proteins

• 

  Subject Areas on Research

  • A blood-based biomarker panel to risk-stratify mild traumatic brain injury. 
  • A mass spectrometry-based probe of equilibrium intermediates in protein-folding reactions. 
  • Bmp signaling is required for intestinal growth and morphogenesis. 
  • Carbonylation of adipose proteins in obesity and insulin resistance: identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal. 
  • First Post-Operative Urinary Kidney Injury Biomarkers and Association with the Duration of AKI in the TRIBE-AKI Cohort. 
  • Heart fatty acid binding protein as a marker for postmortem detection of early myocardial damage. 
  • Human adipocyte lipid-binding protein: purification of the protein and cloning of its complementary DNA. 
  • Human syngeneic intestinal transplantation: evaluation of enterocyte viability with serum levels of intestinal fatty acid binding protein. 
  • Intestinal fatty acid binding protein (I-FABP) for the detection of strangulated mechanical small bowel obstruction. 
  • Intestinal fatty-acid binding protein and metronidazole response in premature infants. 
  • Lack of utility of intestinal fatty acid binding protein levels in predicting intestinal allograft rejection. 
  • Localization of DIR1 at the tissue, cellular and subcellular levels during Systemic Acquired Resistance in Arabidopsis using DIR1:GUS and DIR1:EGFP reporters. 
  • Modulation of ligand binding affinity of the adipocyte lipid-binding protein by selective mutation. Analysis in vitro and in situ. 
  • Ontogeny and nutritional control of adipogenesis in zebrafish (Danio rerio). 
  • Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery. 
  • Phenotypic characterization of transgenic Japanese medaka (Oryzias latipes) that express a red fluorescent protein in hepatocytes. 
  • Short-lived alpha-helical intermediates in the folding of beta-sheet proteins. 
  • Suppressor and activator functions mediated by a repeated heptad sequence in the liver fatty acid-binding protein gene (Fabpl). Effects on renal, small intestinal, and colonic epithelial cell gene expression in transgenic mice. 
  • Systemic inflammatory response syndrome after human syngeneic intestinal transplantation: evidence for disruption of enterocyte barrier function. 
  • The Clinical Utility and Assessment of Renal Biomarkers in Acute Kidney Injury After Abdominal Endovascular Aneurysm Repair. A Systematic Review. 
  • The human olfactory transcriptome. 
  • Tissue-Engineered Human Myobundle System as a Platform for Evaluation of Skeletal Muscle Injury Biomarkers. 
  • Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression. 
  • X-ray crystallographic analysis of adipocyte fatty acid binding protein (aP2) modified with 4-hydroxy-2-nonenal.